Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-Current Debt (2023 - 2025)

AVITA Medical filings provide 3 years of Non-Current Debt readings, the most recent being $42.2 million for Q2 2025.

  • On a quarterly basis, Non-Current Debt rose 2.99% to $42.2 million in Q2 2025 year-over-year; TTM through Jun 2025 was $42.2 million, a 2.99% increase, with the full-year FY2024 number at $42.2 million, up 6.11% from a year prior.
  • Non-Current Debt hit $42.2 million in Q2 2025 for AVITA Medical, up from $41.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $42.5 million in Q3 2024 to a low of $39.8 million in Q4 2023.
  • Median Non-Current Debt over the past 3 years was $41.5 million (2025), compared with a mean of $41.5 million.
  • Biggest five-year swings in Non-Current Debt: rose 6.11% in 2024 and later rose 0.39% in 2025.
  • AVITA Medical's Non-Current Debt stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then fell by 0.07% to $42.2 million in 2025.
  • The last three reported values for Non-Current Debt were $42.2 million (Q2 2025), $41.5 million (Q1 2025), and $42.2 million (Q4 2024) per Business Quant data.